Pharmacokinetic Study in Healthy Adult Volunteers to Assess the Interactions Between Steady-State Tipranavir and Atazanavir in the Presence of Ritonavir

NCT02253836 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Tipranavir
DRUG: Ritonavir
DRUG: Atazanavir

Sponsor

Boehringer Ingelheim